S&T BANK/PA CVS — CVS CORP

Ownership history in S&T BANK/PA  ·  76 quarters on record

AI Ownership Summary

S&T BANK/PA reported CVS CORP (CVS) in 76 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 2.08% in 2023 Q4. The latest visible filing shows CVS at 0.73% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CVS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was S&T BANK/PA's position in CVS CORP, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CVS was reported at 0.73% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
2.08% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CVS stock page S&T BANK/PA fund profile S&T BANK/PA full holdings
How S&T BANK/PA held CVS — position size vs. price
% of Fund (quarterly)    CVS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 27,179 -19,380 -41.6% 0.73% $2.0M 2026-05-13 $98.11
2025 Q4 REDUCED 19.7% -8.8% ✅ 46,559 -11,402 -19.7% 1.17% $3.7M 2026-02-13 $77.80
2025 Q3 REDUCED 20.1% +7.0% ❌ 57,961 -14,586 -20.1% 1.23% $4.4M 2025-11-14 $76.50
2025 Q2 REDUCED 5.6% +10.7% ❌ 72,547 -4,312 -5.6% 1.52% $5.0M 2025-08-06 $61.95
2025 Q1 REDUCED — — — 76,859 -1,101 -1.4% 1.70% $5.2M 2025-05-15 $58.34
2024 Q4 REDUCED 11.2% +52.8% ❌ 77,960 -9,790 -11.2% 1.12% $3.5M 2025-02-14 $62.86
2024 Q3 REDUCED 16.6% -29.4% ✅ 87,750 -17,505 -16.6% 1.45% $5.5M 2024-11-13 $51.17
2024 Q2 REDUCED 17.0% +7.7% ❌ 105,255 -21,554 -17.0% 1.58% $6.2M 2024-08-14 $52.21
2024 Q1 REDUCED 11.2% -26.4% ✅ 126,809 -16,038 -11.2% 1.94% $10.1M 2024-05-15 $51.88
2023 Q4 REDUCED — — — 142,847 -4,261 -2.9% 2.08% $11.3M 2024-02-14 $69.78
66 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding CVS

As of 2026 Q1 — sorted by position size

GLENVIEW CAPITAL MANAGEMENT, LLC 3Y 7Y 14.78% FAIRFAX FINANCIAL HOLDINGS LTD/ CAN 3Y 7Y 10.03% Watchtower Advisors, LP 3Y 9.29% Solel Partners LP 3Y 7.58% Kiltearn Partners LLP 3Y 7Y 7.05% Chieftain Capital Management, Inc. 3Y 7Y 6.9% Strategic Planning, Inc. 5.27% OSLO PENSJONSFORSIKRING AS 5.0% Employees Provident Fund Board 4.31% COLRAIN CAPITAL LLC 3Y 7Y 4.14%

FAQ About S&T BANK/PA and CVS

These are the practical questions this page is built to answer before you even open the full history table.

How long has S&T BANK/PA reported owning CVS?

S&T BANK/PA reported CVS across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported CVS position in S&T BANK/PA's portfolio?

The largest reported portfolio weight for CVS was 2.08% in 2023 Q4.

What is the latest reported CVS position on this page?

The most recent filing on this page is 2026 Q1, when S&T BANK/PA reported 27,179 shares, equal to 0.73% of portfolio, with an estimated market value of $2.0M.

What does the chart on this CVS ownership page compare?

The chart compares S&T BANK/PA's quarterly CVS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did S&T BANK/PA time their CVS position?

Based on 13F filing dates vs. subsequent CVS price moves, S&T BANK/PA correctly timed 25 out of 50 reported position changes (50%). The annualised alpha on CVS relative to SPY over the holding period was +0.5%.

← Back to S&T BANK/PA Holdings